Technical Analysis for AVTX - Avalo Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Doji - Bullish? | Reversal | 4.28% | |
Multiple of Ten Bearish | Other | 4.28% | |
Wide Bands | Range Expansion | 4.28% | |
Down 3 Days in a Row | Weakness | 4.28% | |
Down 4 Days in a Row | Weakness | 4.28% | |
Down 5 Days in a Row | Weakness | 4.28% | |
Oversold Stochastic | Weakness | 4.28% | |
Narrow Range Bar | Range Contraction | 3.73% | |
Multiple of Ten Bearish | Other | 3.73% | |
Wide Bands | Range Expansion | 3.73% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Avalo Therapeutics is a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. The company has built a diverse portfolio of innovative therapies to deliver meaningful medical impact for patients in urgent need. The company’s clinical candidates commonly have a proven mechanistic rationale, biomarkers and/or an established proof-of-concept to expedite and increase the probability of success.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biology Cancer Immunotherapy Biomarkers Precision Medicine Targeted Therapy Innovative Therapies Rare Genetic Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biology Cancer Immunotherapy Biomarkers Precision Medicine Targeted Therapy Innovative Therapies Rare Genetic Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1130.4 |
52 Week Low | 3.9501 |
Average Volume | 843,827 |
200-Day Moving Average | 17.49 |
50-Day Moving Average | 11.55 |
20-Day Moving Average | 13.10 |
10-Day Moving Average | 11.19 |
Average True Range | 1.66 |
RSI (14) | 35.90 |
ADX | 24.49 |
+DI | 21.85 |
-DI | 31.97 |
Chandelier Exit (Long, 3 ATRs) | 12.52 |
Chandelier Exit (Short, 3 ATRs) | 13.89 |
Upper Bollinger Bands | 17.83 |
Lower Bollinger Band | 8.36 |
Percent B (%b) | 0.13 |
BandWidth | 72.31 |
MACD Line | -0.73 |
MACD Signal Line | -0.06 |
MACD Histogram | -0.6717 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 11.32 | ||||
Resistance 3 (R3) | 11.29 | 10.68 | 11.03 | ||
Resistance 2 (R2) | 10.68 | 10.24 | 10.69 | 10.93 | |
Resistance 1 (R1) | 10.13 | 9.97 | 9.83 | 10.17 | 10.84 |
Pivot Point | 9.53 | 9.53 | 9.37 | 9.54 | 9.53 |
Support 1 (S1) | 8.98 | 9.09 | 8.68 | 9.01 | 8.34 |
Support 2 (S2) | 8.37 | 8.81 | 8.39 | 8.25 | |
Support 3 (S3) | 7.83 | 8.37 | 8.15 | ||
Support 4 (S4) | 7.86 |